Novo, Lilly, Novartis Said to Bid for Ascendis Pharma

Novo Nordisk A/S, Novartis AG’S Sandoz and Eli Lilly & Co. are among bidders for Ascendis Pharma A/S of Denmark, a person with knowledge of the matter said.

The Copenhagen-based health-care company received offers of about $400 million, said the person, who declined to be identified because the process isn’t public. Ascendis may choose a final bidder by early September, the person said.